Human placental lactogen levels during and after labor

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Endocrinology

Background:

• Human placental lactogen (HPL) is a key hormone produced by the placenta.
• Assessing fetoplacental function is crucial for managing high-risk pregnancies.
• The utility of HPL as a dynamic indicator during labor requires further investigation.

Purpose of the Study:

• To evaluate human placental lactogen (HPL) levels during labor.
• To determine the value of HPL as an indicator of fetoplacental function in normal and complicated pregnancies.
• To analyze factors influencing HPL levels during the labor process.

Main Methods:

• HPL levels were measured in 225 subjects (normal, preeclamptic, benign intrahepatic cholestasis of pregnancy) before, during, and after labor.
• Comparative analysis of HPL levels between different maternal conditions and fetoplacental function statuses.
• Assessment of HPL half-life post-delivery.

Main Results:

• Greater decreases in HPL levels were observed during labor in preeclamptic subjects compared to normal subjects.
• Similar decreases in HPL were noted in mothers with fetoplacental dysfunction versus those with normal function.
• HPL levels were unaffected by membrane rupture, parity, oxytocin infusion, or placental weight.

Conclusions:

• Significant intrapartum HPL level decreases in preeclampsia and fetoplacental dysfunction may relate to uteroplacental ischemia.
• The dynamic changes in HPL during labor offer limited advantage as a real-time monitor for fetoplacental function.
• Further research is needed to clarify the role of HPL in labor monitoring.